相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。CD4+CD25+FOXP3+ regulatory t cells increase De novo in kidney transplant patients after immunodepletion with Campath-1H
D. D. Bloom et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR study
H. Ekberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Regulatory T cells and T cell depletion: Role of immunosuppressive drugs
Marina Noris et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy
H. P. Tan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial
Marc Hazzan et al.
TRANSPLANTATION (2006)
Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients
David San Segundo et al.
TRANSPLANTATION (2006)
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
Robert Zeiser et al.
BLOOD (2006)
T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients
DD Bloom et al.
TRANSPLANTATION (2006)
The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation
Joseph F. Magliocca et al.
TRANSPLANT INTERNATIONAL (2006)
Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression
SM Flechner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
A function for interleukin 2 in Foxp3-expressing regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2005)
Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin
AD Kirk et al.
TRANSPLANTATION (2005)
Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - Long-term results
DB Kaufman et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
A Vathsala et al.
TRANSPLANTATION (2005)
A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring
G Ciancio et al.
TRANSPLANTATION (2005)
Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil:: Results from a prospective, randomized trial
M Hazzan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: Results of a five-year, prospective, randomized study
D Abramowicz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation - Efficacy and safety at five years
CJE Watson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Kidney transplantation under minimal immunosuppression after pretransplant lymphold depletion with thymoglobulin or campath
R Shapiro et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
Campath-1H in renal transplantation: The University of Wisconsin experience
SJ Knechtle et al.
SURGERY (2004)
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H)
AD Kirk et al.
TRANSPLANTATION (2003)
Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study
SJ Knechtle et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy:: A randomized, prospective, multicenter study
PJHS Gregoor et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Defining the risk of elective cyclosporine withdrawal in stable kidney transplant recipients
S Anjum et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)